HIV patients say ‘no' to IP provision on generic drugs

New Delhi: March 03, 2011

People in Asia living with HIV and who depend on affordable generic AIDS medicines to stay alive have impressed upon the Indian government to stand strong against European Union demands on the sensitive Intellectual Property (IP) chapter in ongoing Free Trade Agreement (FTA) negotiations. The EU is pushing for harmful IP provisions to be included in the trade agreement that will hinder access to quality, affordable generic medicines produced in India, the “pharmacy of the developing world,” they pointed out.

Read more